Drud-induced nephrotoxicity: bibliography from January 2003 to December 2005;Néphrotoxicité des médicaments : veille bibliographique janvier 2003-décembre 2005

Nephrologie et Therapeutique

Volumn 2, Issue 6, 2006, Pages 368-378

  Karie, Svetlana ^a   Launay Vacher, Vincent ^a   Izzedine, Hassane ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Drug induced nephrotoxicity; Electrolyte and acid base abnormalities; Proteinuria; Renal failure

Indexed keywords

ACENOCOUMAROL; ACICLOVIR; ADALIMUMAB; ADEFOVIR; ALEMTUZUMAB; ALENDRONIC ACID; ALLOPURINOL; AMFEBUTAMONE; AMIKACIN; AMIODARONE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ARISTOLOCHIC ACID; ATAZANAVIR; ATORVASTATIN; AZITHROMYCIN; BCG VACCINE; BENIDIPINE; BENZYLTHIOURACIL; CALCIPOTRIOL; CANDESARTAN; CARBAMAZEPINE; CARBIMAZOLE; CEFALEXIN; CEFOPERAZONE; FLUDARABINE; IMATINIB; UNINDEXED DRUG; VALPROIC ACID;

ALLERGIC GLOMERULONEPHRITIS; ARTICLE; CLINICAL PRACTICE; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; EDEMA; GLOMERULUS; HEMATURIA; HUMAN; HYPEREOSINOPHILIA; HYPERKALEMIA; HYPERNATREMIA; HYPOKALEMIA; HYPONATREMIA; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD VESSEL; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY TUBULE; NEPHROTIC SYNDROME; NEPHROTOXICITY; RENOVASCULAR DISEASE;

HUMANS; KIDNEY DISEASES;

EID: 33750461947     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2006.07.013     Document Type: Article

References (60)

1. Karie S., Launay-Vacher V., and Deray G. Néphrotoxicité des médicaments : veille bibliographique janvier-décembre 2003. Néphrologie 25 (2004) 163-168
2. Karie S., Launay-Vacher V., Izzedine H., and Deray G. Néphrotoxicité des médicaments : veille bibliographique janvier 2003-décembre 2004. Néphrologie & Thérapeutique 1 5 (2005) 285-295
3. Lo S.H., Wong K.S., Arlt V.M., Phillips D.H., Lai C.K., Poon W.T., et al. Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy. Am. J. Kidney Dis. 45 2 (2005) 407-410
4. Watanabe T., Nakayasu K., and Nagayama Y. Autoimmune haemolytic anaemia and renal Fanconi syndrome caused by valproate therapy. Eur. J. Pediatr. 164 3 (2005) 186-187
5. Stokes M.B., Foster K., Markowitz G.S., Ebrahimi F., Hines W., Kaufman D., et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol. Dial. Transplant. 20 7 (2005) 1400-1406
6. Osborne W.L., and Lennard A.L. Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabine. Haematologica 90 1 (2005) (ECR05)
7. Pena de la Vega L., Fervenza F.C., Lager D., Habermann T., and Leung N. Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium. Ren. Fail. 27 4 (2005) 485-489
8. Chen I.H., Kuo M.C., Hwang S.J., Chang J.M., and Chen H.C. Allopurinol-induced severe hypersensitivity with acute renal failure. Kaohsiung J. Med. Sci. 21 5 (2005) 228-232
9. Fry A., Saleemi A., Griffiths M., and Farrington K. Acute renal failure following intravesical bacille Calmette-Guerin chemotherapy for superficial carcinoma of the bladder. Nephrol. Dial. Transplant. 20 4 (2005) 849-850
10. Bagley S.C., and Yaeger D. Hyponatremia associated with bupropion, a case verified by rechallenge. J. Clin. Psychopharmacol. 25 1 (2005) 98-99
11. Ortiz A., Justo P., Sanz A., Melero R., Caramelo C., Guerrero M.F., et al. Tubular cell apoptosis and cidofovir-induced acute renal failure. Antivir. Ther. 10 1 (2005) 185-190
12. Ueda H., Ishimura E., Yunoki T., Tsuchida T., Matsumoto N., Jono S., et al. Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA. Clin. Exp. Nephrol. 9 4 (2005) 332-334
13. Miehle K., Paschke R., and Koch C.A. Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): a case report. Pharmacopsychiatry 38 4 (2005) 181-182
14. Paszkowska M., Niemir Z.I., Nowak A., and Czekalski S. Ciprofloxacin-induced acute non-oliguric renal failure in patient with chronic glomerulonephritis. Wiad. Lek. 58 1-2 (2005) 131-133
15. Ortiz M., Mon C., Fernandez M.J., Sanchez R., Mampaso F., and Alvarez Ude F. [Tubulointerstitial nephritis associated with treatment with selective Cox-2 inhibitors, celecoxib and rofecoxib]. Nefrologia 25 1 (2005) 39-43
16. Esteve J.B., Launay-Vacher V., Brocheriou I., Grimaldi A., and Izzedine H. COX-2 inhibitors and acute interstitial nephritis: case report and review of the literature. Clin. Nephrol. 63 5 (2005) 385-389
17. Clifford T.M., Pajoumand M., and Johnston T.D. Celecoxib-induced nephrotoxicity in a renal transplant recipient. Pharmacotherapy 25 5 (2005) 773-777
18. Kallel H., Hamida C.B., Ksibi H., Bahloul M., Hergafi L., Chaari A., et al. Suspected acute interstitial nephritis induced by colistin. J. Nephrol. 18 3 (2005) 323-326
19. Daram S.R., Gogia S., and Bastani B. Colistin-associated acute renal failure: revisited. South. Med. J. 98 2 (2005) 257-258
20. Geevasinga N., Kairaitis L., Rangan G.K., and Coleman P.L. Acute interstitial nephritis secondary to esomeprazole. Med. J. Aust. 182 5 (2005) 235-236
21. McBryde K.D., Wilcox J., and Kher K.K. Hyperphosphatemia due to fosphenytoin in a pediatric ESRD patient. Pediatr. Nephrol. 20 8 (2005) 1182-1185
22. Lewin S.N., Mutch D.G., Whitcomb B.P., Liapis H., and Herzog T.J. Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin. Gynecol. Oncol. 97 1 (2005) 228-233
23. Desrame J., Duvic C., Bredin C., Bechade D., Artru P., Brezault C., et al. Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature. Rev. Med. Interne 26 3 (2005) 179-188
24. Muller S., Schutt P., Bojko P., Nowrousian M.R., Hense J., Seeber S., et al. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann. Hematol. 84 2 (2005) 110-114
25. Saif M.W., and McGee P.J. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature. JOP 6 4 (2005) 369-374
26. Pfister C. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann. Hematol. 84 9 (2005) 621-622
27. Foringer J.R., Verani R.R., Tjia V.M., Finkel K.W., Samuels J.A., and Guntupalli J.S. Acute renal failure secondary to imatinib mesylate treatment in prostate cancer. Ann. Pharmacother. 39 12 (2005) 2136-2138
28. Chin G., Luxton G., and Harvey J.M. Infliximab and nephrotic syndrome. Nephrol. Dial. Transplant. 20 12 (2005) 2824-2826
29. Goyal H.K., Wadhwa J., Arora B., Dawar R., Agarwal S.K., and Singh D. Interferon-induced lupus nephritis in a patient with chronic myeloid leukemia. Leuk. Lymphoma 46 3 (2005) 481-482
30. Auty A., and Saleh A. Nephrotic syndrome in a multiple sclerosis patient treated with interferon beta1a. Can. J. Neurol. Sci. 32 3 (2005) 366-368
31. Alexandrescu D.T., Maddukuri P., Wiernik P.H., and Dutcher J.P. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanoma. J. Immunother. 28 2 (2005) 144-147
32. Nasrallah K., and Silver B. Hyponatremia associated with repeated use of levetiracetam. Epilepsia 46 6 (2005) 972-973
33. Hirota K., Hara T., Hosoi S., Sasaki Y., Hara Y., and Adachi T. Two cases of hyperkalemia after administration of hypertonic mannitol during craniotomy. J. Anesth. 19 1 (2005) 75-77
34. Nagao J., Tsukuda M., Yoshida T., Sakuma N., Matsuda H., and Mikami Y. [A case of head and neck squamous cell carcinoma suffering from acute renal failure after methotrexate administrator]. Gan To Kagaku Ryoho 32 6 (2005) 821-823
35. Lau K.K., Weiss A.R., and Jones D.P. Polyuria associated with high-dose methotrexate in two patients with acute lymphoblastic leukaemia. J. Oncol. Pharm. Pract. 11 1 (2005) 31-33
36. Tadic M., Grgurevic I., Scukanec-Spoljar M., Bozic B., Marusic S., Horvatic I., et al. Acute interstitial nephritis due to mesalazine. Nephrology (Carlton) 10 2 (2005) 103-105
37. Argirov M., Ricken G., Zecher D., and Fischereder M. Acute interstitial nephritis associated with moxifloxacin use. Clin. Ther. 27 8 (2005) 1260-1263
38. Labaye J., Sarret D., Duvic C., Herody M., Didelot F., Nedelec G., et al. Renal toxicity of oxaliplatin. Nephrol. Dial. Transplant. 20 6 (2005) 1275-1276
39. Geevasinga N., Coleman P.L., and Roger S.D. Rabeprazole-induced acute interstitial nephritis. Nephrology (Carlton) 10 1 (2005) 7-9
40. Ireland J.H., Eggert C.H., Arendt C.J., and Williams A.W. Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate. Ann. Intern. Med. 142 11 (2005) 949-950
41. Iskra B., Zivko M., and Kes P. Rhabdomyolysis as a side effect of simvastatin treatment. Acta Med. Croatica 59 4 (2005) 325-328
42. Izzedine H., Brocheriou I., and Frances C. Post-transplantation proteinuria and sirolimus. N. Engl. J. Med. 353 19 (2005) 2088-2089
43. Mainra R., Mulay A., Bell R., Karpinski J., Hoar S., Knoll G., et al. Sirolimus use and de novo minimal change nephropathy following renal transplantation. Transplantation 80 12 (2005) 1816
44. Guitard J., Kamar N., Mouzin M., Borde J.S., Tran-Van T., Durand D., et al. Sulfadiazine-related obstructive urinary tract lithiasis: an unusual cause of acute renal failure after kidney transplantation. Clin. Nephrol. 63 5 (2005) 405-407
45. Toprak O., Cirit M., Ersoy R., Uzum A., Ozumer O., Cobanoglu A., et al. New-onset type II diabetes mellitus, hyperosmolar non-ketotic coma, rhabdomyolysis and acute renal failure in a patient treated with sulpiride. Nephrol. Dial. Transplant. 20 3 (2005) 662-663
46. Parsonage M.J., Wilkins E.G., Snowden N., Issa B.G., and Savage M.W. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med. 6 5 (2005) 341-346
47. Quimby D., and Brito M.O. Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature. AIDS Read. 15 7 (2005) 357-364
48. Malik A., Abraham P., and Malik N. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature. J. Infect. 51 2 (2005) E61-E65
49. Harmouche H., Le Bras P., Bignani O., Delfraissy J.F., and Goujard C. Insuffisance rénale aiguë avec diabète insipide et syndrome de Fanconi chez un patient infecté par le virus de l'immunodéficience humaine traité par Ténofovir. Rev. Med. Interne 26 6 (2005) 522-523
50. Krummel T., Parvez-Braun L., Frantzen L., Lalanne H., Marcellin L., Hannedouche T., et al. Tenofovir-induced acute renal failure in an HIV patient with normal renal function. Nephrol. Dial. Transplant. 20 2 (2005) 473-474
51. Juss J.K., Radhamma A.K., and Forsyth D.R. Tolterodine-induced hyponatraemia. Age Ageing 34 5 (2005) 524-525
52. Zuliani E., Zwahlen H., Gilliet F., and Marone C. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin. Nephrol. 64 2 (2005) 155-158
53. Munier A., Gras V., Andrejak M., Bernard N., Jean-Pastor M.J., Gautier S., et al. Zoledronic Acid and renal toxicity: data from French adverse effect reporting database. Ann. Pharmacother. 39 7-8 (2005) 1194-1197
54. Lo S.H., Mo K.L., Wong K.S., Poon S.P., Chan C.K., Lai C.K., et al. Aristolochic acid nephropathy complicating a patient with focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 19 7 (2004) 1913-1915
55. Ruiz I., Del Valle J., and Gomez A. Gemcitabine and haemolytic-uraemic syndrome. Ann. Oncol. 15 10 (2004) 1575-1576
56. Nahshoni E., Weizman A., Shefet D., and Pik N. A case of hyponatremia associated with escitalopram. J. Clin. Psychiatry 65 12 (2004) 1722
57. Rogowska E., and Wozniak W. Nephrotoxicity of ifosfamide with special reference to Fanconi Syndrome. Med. Wieku Rozwoj. 8 2 Pt 1 (2004) 289-295
58. Fisher M.E., Rossini M., Simmons E., Harris R.C., Moeckel G., and Zent R. A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy. Am. J. Kidney Dis. 44 3 (2004) 567-573
59. Saumoy M., Vidal F., Peraire J., Sauleda S., Vea A.M., Vilades C., et al. Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?. AIDS 18 12 (2004) 1741-1742
60. Ferretti G., Petti M.C., Carlini P., Zeuli M., Picardi A., Meloni G., et al. Zoledronic acid-associated thrombotic thrombocytopenic purpura. Ann. Oncol. 15 12 (2004) 1847-1848